Documents & Downloads

HPV16 E7 (86-93)

Human Leukocyte Antigen

HPV16 E7 (86-93) is a peptide derived from the HPV16 E7 protein, restricted by the human leukocyte antigen HLA-A2.1. This peptide exhibits immunogenic activity, making it a valuable tool for research focused on cervical carcinomas and immune response mechanisms related to HPV-associated cancers. It is useful for studies on T cell recognition and vaccine development targeting HPV-related malignancies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	160212-93-1
Applications	Human Leukocyte Antigen
Formula	C₃₇H₆₆N₈O₁₀S
Molecular Weight	815.03
SMILES	C([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@H]([C@@H](C)O)N)=O)CC(C)C)=O)=O)[C@H](CC)C)=O)C(C)C)=O)CS)(=O)N1[C@H](C(N[C@@H]([C@H](CC)C)C(O)=O)=O)CCC1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.